Point of Service Diabetes Screening Evaluation (POSSE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
VeraLight, Inc.
ClinicalTrials.gov Identifier:
NCT01669616
First received: July 23, 2012
Last updated: January 13, 2013
Last verified: January 2013

July 23, 2012
January 13, 2013
August 2012
January 2013   (final data collection date for primary outcome measure)
To compare the accuracy of SCOUT DS versus random capillary glucose and several diabetes risk assessment questionnaires for detection of HbA1c-defined dysglycemia. [ Time Frame: one week ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01669616 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Point of Service Diabetes Screening Evaluation
Point of Service Diabetes Screening Evaluation

The primary objective of the trial is to collect SCOUT DS, random capillary glucose and Hemoglobin A1c measurements from subject 18 years of age or older.

The objectives of this study are to compare the accuracy of SCOUT versus random capillary glucose and several diabetes risk assessment questionnaires for detection of HbA1C-defined dysglycemia.

Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Attendees of Blue Cross Blue Shield Wellness Event

Diabetes Mellitus, Non-Insulin Dependent
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
667
January 2013
January 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age or older

Exclusion Criteria:

  • Known to be pregnant (self-reported)
  • Receiving dialysis or known renal compromise
  • Known to have photosensitivity
  • Taking medications that fluoresce
  • Have scars, any tattoos, rashes or other disruption/discoloration on the left volar forearm
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01669616
VL-2723
No
VeraLight, Inc.
VeraLight, Inc.
Not Provided
Principal Investigator: Andrea Barrack, MD Blue Cross Blue Shield of Louisiana
VeraLight, Inc.
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP